Kirkland Lake Gold Ltd.
KL
recently released gold production figures for the first quarter of 2021.
Consolidated gold production fell 8.5% year over year to 302,847 ounces in the first quarter, but surpassed the company’s guidance of 270,000-290,000 ounces. Consolidated gold sales declined 10.6% year over year to 308,029 ounces. The company’s average realized price of gold was $1,788 per ounce in the first quarter compared with $1,586 in the prior-year quarter.
The company witnessed quarterly production at Fosterville to decline 32% year over year to 108,679 ounces in the first quarter. However, production levels were higher than target due to grade outperformance in the Swan zone in March.
Production from the Detour Lake Mine totaled 146,731 ounces in the first quarter, marking a 6.3% increase year over year. Production, however, fell sequentially that reflects reduced mill throughput with first-quarter processing rates typically the lowest of the year due to seasonal factors. The company also witnessed record level for first-quarter processing in the first quarter and achieved a new daily throughput record of 80,339 tonnes on Mar 24, 2021.
At Macassa, gold production totaled 47,437 ounces in the first quarter, down 6.7% year over year. The year-over-year decline is attributable to lower tons processed.
As of Mar 31, 2021, the company’s cash position was $792 million with no debt.
The company’s shares have inched up 0.9% in the past year compared with 3% rise of the
industry
.
Zacks Rank & Key Picks
Kirkland Lake Gold currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the basic materials space are
Fortescue Metals Group Limited
FSUGY
,
Nucor Corporation
NUE
and
Impala Platinum Holdings Limited
IMPUY
.
Fortescue has a projected earnings growth rate of 106.5% for the current fiscal. The company’s shares have surged 124.5% in a year. It currently flaunts a Zacks Rank #1 (Strong Buy). You can see
the complete list of today’s Zacks #1 Rank stocks here.
Nucor has an expected earnings growth rate of 135.3% for the current fiscal. The company’s shares have gained 120.3% in the past year. It currently sports a Zacks Rank #1.
Impala has an expected earnings growth rate of 197.6% for the current fiscal. The company’s shares have rallied 203.4% in the past year. It currently flaunts a Zacks Rank #1.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report